Correlation Between Bellicum Pharmaceuticals and SAB Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Bellicum Pharmaceuticals and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellicum Pharmaceuticals and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bellicum Pharmaceuticals and SAB Biotherapeutics, you can compare the effects of market volatilities on Bellicum Pharmaceuticals and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellicum Pharmaceuticals with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellicum Pharmaceuticals and SAB Biotherapeutics.

Diversification Opportunities for Bellicum Pharmaceuticals and SAB Biotherapeutics

0.0

Correlation Coefficient

Bellicum Pharmaceuticals  SAB Biotherapeutics

Pay attention - limited upside

The 3 months correlation between Bellicum and SAB is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bellicum Pharmaceuticals and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Bellicum Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellicum Pharmaceuticals are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Bellicum Pharmaceuticals i.e., Bellicum Pharmaceuticals and SAB Biotherapeutics go up and down completely randomly.

Pair Corralation between Bellicum Pharmaceuticals and SAB Biotherapeutics

If you would invest  10.00  in SAB Biotherapeutics on December 19, 2024 and sell it today you would lose (7.49) from holding SAB Biotherapeutics or give up 74.9% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Bellicum Pharmaceuticals  vs.  SAB Biotherapeutics

Bellicum Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bellicum Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Bellicum Pharmaceuticals is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

SAB Biotherapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bellicum Pharmaceuticals and SAB Biotherapeutics

The main advantage of trading using opposite Bellicum Pharmaceuticals and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellicum Pharmaceuticals position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.

The idea behind Bellicum Pharmaceuticals and SAB Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.